ALLMedicine™ Cardiovascular Disease Center

Mar 1st, 2021 - It remains unclear which blood pressure (BP) characteristics best predict cardiovascular risk in different age groups and between sexes. We leveraged data from the MORGAM (MONICA [Monitoring of Trends and Determinants in Cardiovascular Disease], R...

Mar 1st, 2021 - The 2017 American College of Cardiology/American Heart Association high blood pressure (BP) guidelines recommend risk assessment of atherosclerotic cardiovascular disease to inform hypertension treatment in adults with elevated BP or low-risk stag...

Mar 1st, 2021 - Treatment and control rates for high blood pressure are unsatisfactory in young adults. Adherence to pharmacological treatment is alarmingly low, with absence of data on its consequences in young adults with hypertension. We investigated the assoc...

Mar 1st, 2021 - The neuropeptide CGRP (calcitonin gene-related peptide) is a potent vasodilator, with a cardioprotective role, although the precise mechanisms are unclear. Here we show the ability of endogenous and exogenous CGRP to restore blood pressure, when n...

Mar 1st, 2021 - The United Kingdom was among the first countries to introduce a salt reduction program in 2003 to reduce cardiovascular disease (CVD) incidence risk. Despite its initial success, the program has stalled recently and is yet to achieve national and ...

Feb 22nd, 2021 - Statins reduce cardiovascular disease events in primary and secondary prevention, in men and women, and across all age groups.12 Systematic reviews and meta-analyses of randomised trials have confirmed the safety of statins.3 Although severe adver...

Feb 15th, 2021 - ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization.|2021|Driggin E,Morris AA,Maddox TM,Mullen JB,Ferdinand KC,|

Feb 1st, 2021 - Although the attention of the world and the global health community specifically is deservedly focused on the COVID-19 pandemic, other determinants of health continue to have large impacts and may also interact with COVID-19. Air pollution is one ...

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

Nov 30th, 2020 - 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Re...

Mar 1st, 2021 - It remains unclear which blood pressure (BP) characteristics best predict cardiovascular risk in different age groups and between sexes. We leveraged data from the MORGAM (MONICA [Monitoring of Trends and Determinants in Cardiovascular Disease], R...

Mar 1st, 2021 - The 2017 American College of Cardiology/American Heart Association high blood pressure (BP) guidelines recommend risk assessment of atherosclerotic cardiovascular disease to inform hypertension treatment in adults with elevated BP or low-risk stag...

Mar 1st, 2021 - Treatment and control rates for high blood pressure are unsatisfactory in young adults. Adherence to pharmacological treatment is alarmingly low, with absence of data on its consequences in young adults with hypertension. We investigated the assoc...

Mar 1st, 2021 - The neuropeptide CGRP (calcitonin gene-related peptide) is a potent vasodilator, with a cardioprotective role, although the precise mechanisms are unclear. Here we show the ability of endogenous and exogenous CGRP to restore blood pressure, when n...

Mar 1st, 2021 - The United Kingdom was among the first countries to introduce a salt reduction program in 2003 to reduce cardiovascular disease (CVD) incidence risk. Despite its initial success, the program has stalled recently and is yet to achieve national and ...

Feb 28th, 2021 - Ketone bodies may have therapeutic benefits for patients with cardiovascular disease (CVD), regardless of the method used to increase their presence in the heart, a new review suggests. The authors looked at the current body of experimental and cl...

Feb 23rd, 2021 - Long-term use of continuous positive airway pressure (CPAP) was associated with higher self-reported physical activity levels in adults with co-occurring obstructive sleep apnea (OSA) and cardiovascular disease (CVD), in new research. "The aim of ...

Feb 23rd, 2021 - People who mostly ate foods with a low glycemic index had a lower likelihood of premature death and major cardiovascular disease (CVD) events compared with those whose diet included more "poor quality" food with a high glycemic index. The results ...

Feb 22nd, 2021 - Statins reduce cardiovascular disease events in primary and secondary prevention, in men and women, and across all age groups.12 Systematic reviews and meta-analyses of randomised trials have confirmed the safety of statins.3 Although severe adver...

Feb 10th, 2021 - Patients with type 2 diabetes and the highest level of variability in their A1c levels over 2 years had significantly more first cardiovascular disease (CVD) events than similar patients with less A1c variability, in a retrospective analysis of mo...